Endo to buy privately held Qualitest for $1.2 billion

BANGALORE (Reuters) – Endo Pharmaceuticals Holdings Inc said it agreed to buy privately held generics company Qualitest Pharmaceuticals for about $1.2 billion in cash to expand its portfolio of pain drugs, marking its second acquisition in as many months.

Leave a Reply